
Alice Schwartz
$1.76B
as of 04/01/25
About Alice Schwartz
With $720 in savings, Alice Schwartz and her husband David launched Bio-Rad Laboratories in a Berkeley Quonset hut in 1952.
Early products included ion exchange resins, substances used to facilitate pharmaceutical manufacturing and lab research.
Bio-Rad now sells 10,000 life science research and clinical diagnostics products and had 2023 revenues of $2.7 billion.
Bio-Rad held its IPO in 1966. It was listed on the American Stock Exchange in 1980, then the New York Stock Exchange in 2008.
Schwartz, who was widowed in 2012, stepped down from the board in 2022; her son Norman is chairman and CEO.
Personal stats
Citizenship
United States of AmericaSource of wealth
BiotechResidence
El Cerrito, CaliforniaMarital status
WidowedBirth date
07/02/26 (age 98)Number of children
2Education
Bachelor of Arts/Science, University of California, BerkeleySelf-made
self-madeAlice Schwartz’s fortune is worth

29K
troy ounces of gold

27K
median U.S. household

18K
median U.S. income

0.035%
U.S. credit card volume

0.007%
GDP of the United States

0.005%
United States debt
Net worth history
Annual ranking
Did you know?
Bio-Rad's products include a screening kit for cancerous genetic mutations and an HIV test that analyzes antibodies and antigens for early virus detection.
Net worth over time
Real-time ranking
Financial assets
NYSE | BIO-US
Bio-Rad class ANYSE | BIO.B-US
Bio-Rad class BImages © Forbes.com. All rights reserved.